DRUGRECURE APS has a total of 46 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals are SpineThera, KOMINOX INC and WEDGE STEPHEN ROBERT.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Canada | 5 | |
#4 | Australia | 4 | |
#5 | Brazil | 4 | |
#6 | Japan | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Argentina | 2 | |
#9 | China | 2 | |
#10 | Israel | 2 | |
#11 | Norway | 2 | |
#12 | South Africa | 2 | |
#13 | Hong Kong | 1 | |
#14 | Mexico | 1 | |
#15 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Uttenthal Lars Otto | 20 |
#2 | Fiala Kaare | 12 |
#3 | Ganslandt Cecilia | 5 |
#4 | Tarnow Inge | 5 |
#5 | Wylam Mark E | 4 |
#6 | Kaare Fiala | 3 |
#7 | Otto Uttenthal Lars | 3 |
#8 | Inge Tarnow | 1 |
#9 | Wylam Mark | 1 |
#10 | Cecilia Ganslandt | 1 |
Publication | Filing date | Title |
---|---|---|
EP3697432A1 | Gm-csf for treating refractory non-tuberculous mycobacteria infections | |
WO2008116470A1 | Enhancing pulmonary host defence via administration of granulocyte- colony stimulating factor | |
CA2672261A1 | Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin | |
WO2008052567A2 | Enhancing pulmonary host defense via administration of granulocyte-macrophage colony stimulating factor | |
WO2007104317A1 | Methods for local treatment with factor vii | |
AU2006273696A1 | Airway administration of activated protein C in inflammatory conditions affecting the respiratory tract |